These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 32788926

  • 1. Recombinant Human Brain Natriuretic Peptide Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting CD4+ T Cell Proliferation via PI3K/AKT/mTOR Pathway Activation.
    Li KP, Zhang HY, Xu XD, Ming-Yang, Li TJ, Song ST.
    Cardiovasc Ther; 2020; 2020():1389312. PubMed ID: 32788926
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human brain natriuretic peptide regulates PI3K/AKT/mTOR pathway through lncRNA EGOT to attenuate hypoxia-induced injury in H9c2 cardiomyocytes.
    Zhang C, Pan S, Aisha A, Abudoukelimu M, Tang L, Ling Y.
    Biochem Biophys Res Commun; 2018 Sep 10; 503(3):1186-1193. PubMed ID: 30031611
    [Abstract] [Full Text] [Related]

  • 3. Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling.
    Liu Q, Li Z, Liu Y, Xiao Q, Peng X, Chen Q, Deng R, Gao Z, Yu F, Zhang Y.
    Cardiovasc Ther; 2018 Dec 10; 36(6):e12481. PubMed ID: 30597772
    [Abstract] [Full Text] [Related]

  • 4. Gastrodin protects myocardial cells against hypoxia/reoxygenation injury in neonatal rats by inhibiting cell autophagy through the activation of mTOR signals in PI3K-Akt pathway.
    Li X, Zhu Q, Liu Y, Yang Z, Li B.
    J Pharm Pharmacol; 2018 Feb 10; 70(2):259-267. PubMed ID: 29148068
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z, Tong G, Ma N, Li J, Li X, Li S, Zhou J, Xiong L, Cao F, Yao L, Wang H, Shen L.
    Basic Res Cardiol; 2013 May 10; 108(3):341. PubMed ID: 23463182
    [Abstract] [Full Text] [Related]

  • 7. Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway.
    Zhang P, Wang J, Wang X, Wang L, Xu S, Gong P.
    J Cardiovasc Transl Res; 2024 Apr 10; 17(2):376-387. PubMed ID: 37580643
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway.
    Do Carmo H, Arjun S, Petrucci O, Yellon DM, Davidson SM.
    Cardiovasc Drugs Ther; 2018 Apr 10; 32(2):165-168. PubMed ID: 29582211
    [Abstract] [Full Text] [Related]

  • 10. Remote ischemic postconditioning alleviates myocardial ischemia/reperfusion injury by up-regulating ALDH2.
    Zhang ZX, Li H, He JS, Chu HJ, Zhang XT, Yin L.
    Eur Rev Med Pharmacol Sci; 2018 Oct 10; 22(19):6475-6484. PubMed ID: 30338817
    [Abstract] [Full Text] [Related]

  • 11. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW, Yang F, Cheng SZ, Liu Y, Wan LH, Cong HL.
    Cardiovasc Ther; 2017 Feb 10; 35(1):3-9. PubMed ID: 27580017
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.
    Ha T, Hua F, Liu X, Ma J, McMullen JR, Shioi T, Izumo S, Kelley J, Gao X, Browder W, Williams DL, Kao RL, Li C.
    Cardiovasc Res; 2008 Jun 01; 78(3):546-53. PubMed ID: 18267957
    [Abstract] [Full Text] [Related]

  • 14. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
    Sánchez JA, Rodríguez-Sinovas A, Barba I, Miró-Casas E, Fernández-Sanz C, Ruiz-Meana M, Alburquerque-Béjar JJ, García-Dorado D.
    Basic Res Cardiol; 2013 May 01; 108(3):351. PubMed ID: 23595215
    [Abstract] [Full Text] [Related]

  • 15. Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux.
    Xuan F, Jian J.
    Int J Mol Med; 2016 Jul 01; 38(1):328-36. PubMed ID: 27246989
    [Abstract] [Full Text] [Related]

  • 16. Signalling during an ischaemic preconditioning protocol: new role players?
    Lochner A.
    Cardiovasc Res; 2011 Apr 01; 90(1):5-6. PubMed ID: 21307089
    [No Abstract] [Full Text] [Related]

  • 17. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling.
    Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, Hua F, Xu G, Yu P.
    Sci Rep; 2014 Dec 04; 4():7317. PubMed ID: 25471136
    [Abstract] [Full Text] [Related]

  • 18. Choline Inhibits Ischemia-Reperfusion-Induced Cardiomyocyte Autophagy in Rat Myocardium by Activating Akt/mTOR Signaling.
    Hang P, Zhao J, Su Z, Sun H, Chen T, Zhao L, Du Z.
    Cell Physiol Biochem; 2018 Dec 04; 45(5):2136-2144. PubMed ID: 29533930
    [Abstract] [Full Text] [Related]

  • 19. N,N-dimethylsphingosine attenuates myocardial ischemia-reperfusion injury by recruiting regulatory T cells through PI3K/Akt pathway in mice.
    Fang J, Hu F, Ke D, Yan Y, Liao Z, Yuan X, Wu L, Jiang Q, Chen L.
    Basic Res Cardiol; 2016 May 04; 111(3):32. PubMed ID: 27048490
    [Abstract] [Full Text] [Related]

  • 20. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J.
    Cardiovasc Res; 2008 Apr 01; 78(1):116-22. PubMed ID: 18222959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.